Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$520,800
-$5,488,294 QoQ
Shares Held
1,860
-91.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#573
of 1,044 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $727,870,777 across 19 Diagnostics & Research names. LH ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
449,628 | $225,425,494 | |
| 2 | DHR |
Danaher Corp /De/
|
759,207 | $144,613,749 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
700,425 | $135,336,117 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
54,686 | $69,861,911 | |
| 5 | DGX |
Quest Diagnostics Inc
|
275,371 | $58,364,883 | |
| 6 | WAT |
Waters Corp /De/
|
138,443 | $51,921,662 | |
| 7 | GH |
Guardant Health, Inc.
|
124,368 | $18,658,930 | |
| 8 | RVTY |
Revvity, Inc.
|
63,056 | $7,015,610 |
All Filings in LH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,800 | 1,860 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,009,094 | 22,522 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,389,952 | 45,400 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,945,993 | 118,254 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,564,572 | 85,957 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||